66--(WLR) Leukemia Lymphoma markers for Flow Cytometry; and Ancillary reagents for flow cytometry

The Great Lakes Acquisition Center (GLAC) plans to enter into a sole source contract with Beckman Coulter to supply reagents and ancillary materials specifically for Leukemia and Lymphoma testing at the Clement J. Zablocki VA Medical Center in Milwaukee, Wisconsin. This contract will support testing on an existing Beckman Coulter instrument used for Flow Cytometry and will cover a period of 35 months. The procurement process follows FAR 13.106 (1)(b), indicating that Beckman Coulter is the only provider capable of meeting the agency’s technical requirements, and therefore no competitive bidding is planned. However, other firms that believe they can fulfill the contract specifications were invited to submit written evidence demonstrating their capabilities by August 30, 2016, although telephonic inquiries and solicitation documents were not available. The contract falls under NAICS code 325413 and is managed by the Department of Veterans Affairs, Network Contract Office 12, based in Milwaukee. The acquisition aligns with the necessity to maintain continuity and compatibility with existing laboratory equipment tied to Flow Cytometry analysis for leukemia and lymphoma markers. While the government retains the discretion to consider any alternative proposals received, the absence of qualified responses will result in the award proceeding solely with Beckman Coulter. The contract specifics, including solicitation number VA69D16Q1127 and points of contact, were communicated through official channels to ensure transparency and compliance with federal acquisition regulations.